Table 3.
Group (S) | Treatment (mg/kg; p.o.) | Total protein (g/dl) | % change from baseline | |
---|---|---|---|---|
Initial | Final | |||
I. Normal | Untreated | 7.43 ± 0.62 | 8.85 ± 0.92 | +19 |
II. Control | Vehicle Orally | 4.10 ± 0.31 | 4.45 ± 0.28** | +08 |
III. ATV | 10 | 4.15 ± 0.46 | 4.35 ± 0.18 ns | +05 |
IV. HCQ | 200 | 4.39 ± 0.12 | 4.96 ± 0.46 ns | +13 |
V. ATV + HCQ | 5 + 100 | 4.23 ± 0.18 | 5.26 ± 0.74* | +24 |
VI. ATV + HCQ | 10 + 200 | 4.29 ± 0.27 | 6.00 ± 0.68** | +40 |
Values are expressed as Mean ± S.D. (n= 6). Statistical analysis was carried out by one way analysis of variance (ANOVA) followed by Students t-test.
P<0.05;
P<0.01: ns P>0.05 (non-significant). Results of Gr. I was compared with Gr. II and Gr. II results with Gr. III, IV, V and VI. ATV- Atorvastatin, HCQ- Hydroxychloroquine